Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Sarepta Therapeutics (NQ: SRPT )

87.06 USD +1.81 (+2.12%)
Official Closing Price Updated: 7:58 PM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,567,277
Open 85.87
Bid (Size) 86.75 (1)
Ask (Size) 87.00 (3)
Prev. Close 85.25
Today's Range 82.27 - 87.68
52wk Range 77.01 - 181.83
Shares Outstanding 65,531,046
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
Sarepta Therapeutics Announces FDA Approval of AMONDYS 45™ (casimersen) Injection for the Treatment of Duchenne Muscular Dystrophy (DMD) in Patients Amenable to Skipping Exon 45
From GlobeNewswire News Releases

Performance

YTD
-47.33%
-47.33%
1 Month
-3.79%
-3.79%
3 Month
-37.43%
-37.43%
6 Month
-40.96%
-40.96%
1 Year
-19.14%
-19.14%

More News

Read More
Sarepta Therapeutics to Present at Upcoming Investor Conferences
From GlobeNewswire News Releases
Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2020 Financial Results and Recent Corporate Developments on March 1, 2021
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT
From PR Newswire
Sarepta Therapeutics Announces Winners of the “Rare Lessons” Lesson Planning Competition
From GlobeNewswire News Releases
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sarepta Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
From PR Newswire
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
Earnings Preview: Sarepta Therapeutics
Tags BZI/EP Benzinga Earnings
From Benzinga
FBT's Underlying Holdings Could Mean 16% Gain Potential
Tags ETFs
From ETF Channel
How Will Biden's Executive Orders Affect Your Healthcare Stocks?
Tags QDEL FLGT Market News
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.